As New Tech Emerges For Early Research, FDA Chief Scientist Says Diversity Must Start In Preclinical Development

 
• By Sarah Karlin-Smith
Namandjé_Bumpus_organ_on_a_chip
• Source: Nielsen Hobbs; the Pink Sheet | Shutterstock, FDA images

More from Leadership

More from Medtech Insight